Eclincloud - About the company
Eclincloud is a series A company based in Shenzhen (China), founded in 2020. It operates as a Cloud-based drug development software for researchers. Eclincloud has raised an undisclosed amount in funding. The company has 41 active competitors, including 15 funded and 4 that have exited. Its top competitors include companies like Enveda, Nura Bio and Kvantify.
Company Details
- Website
- www.eclincloud.com
- Email ID
- *****@eclincloud.com
- Phone Number
- +86 **********
Key Metrics
Founded Year
2020
Location
Shenzhen, China
Stage
Series A
Latest Funding Round
Investors
Ranked
30th among 41 active competitors
Employee Count
20 as on Aug 31, 2026
Sign up to download Eclincloud's company profile
Eclincloud's funding and investors
Eclincloud has raised funding over 1 round. Its latest funding round was a Series A round on Dec 01, 2021 for $*****. 1 investor participated in its latest round. Eclincloud has 1 institutional investor.
Here is the list of recent funding rounds of Eclincloud:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 01, 2021 | 5462836 | Series A | 3813669 | 8783369 | 1352023 | 4696470 |
View details of Eclincloud's funding rounds and investors
Eclincloud's founders and board of directors
Founder? Claim ProfileEclincloud's employee count trend
Eclincloud has 20 employees as of Aug 26. Here is Eclincloud's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Eclincloud's Competitors and alternates
Top competitors of Eclincloud include Enveda, Nura Bio and Kvantify. Here is the list of Top 10 competitors of Eclincloud, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Enveda 2019, Boulder (United States), Series E | AI-based platform to decipher the chemistry of nature and develop new medicines | $845M | 63/100 | |
2nd | Nura Bio 2018, San Francisco (United States), Series B | Provider of solution for diagnosis of a neurological disorder and neuroprotective medicines | $215M | 59/100 | |
3rd | Provider of quantum computing solutions for businesses in industries such as finance, life sciences, and logistics | $18.9M | 58/100 | ||
4th | Diagonal Therapeutics 2022, Cambridge (United States), Series B | Developer of antibody therapeutics for the treatment of rare diseases | $253M | 55/100 | |
5th | IMIDomics 2015, San Francisco (United States), Series A | Developer of medicines for the treatment of immune-mediated inflammatory diseases | $16.5M | 51/100 | |
6th | revalia bio 2021, New Haven (United States), Seed | Provider of contract based drugs development services for biopharma sector | $26.8M | 54/100 | |
7th | QSimulate 2018, Cambridge (United States), Seed | Laboratory focused on developing of quantitative simulation tools to help in quantum molecular | $11M | 53/100 | |
8th | Applied BioMath 2013, Cambridge (United States), Acquired | Systems biology and pharmacology modeling services to aid drug discovery and development | $2.32M | 48/100 | |
9th | Cresset 2002, Cambridge (United Kingdom), Seed | Provider of software solutions for computational chemistry | $298K | 44/100 | |
10th | Nimble Therapeutics 2019, Madison (United States), Acquired | Provider combinatorial chemistry-related drug discovery services | $10M | 41/100 | |
30th | Eclincloud 2020, Shenzhen (China), Series A | Cloud-based drug development software for researchers | - | 22/100 |
Looking for more details on Eclincloud's competitors? Click here to see the top ones
Eclincloud's Investments and acquisitions
Eclincloud has made no investments or acquisitions yet.
Reports related to Eclincloud
Here is the latest report on Eclincloud's sector:
News related to Eclincloud
Media has covered Eclincloud for 1 event in last 1 year, It was about company updates.
•
EClinCloud's AI-Driven Clinical Research Platform Expands to Over 1,100 Trials in 10+ CountriesPR Newswire•Sep 03, 2026•Eclincloud
Are you a Founder ?
FAQs about Eclincloud
Explore our recently published companies
- Learn With AI - United Kingdom based, Unfunded company
- Digital Twin AI - United Kingdom based, Unfunded company
- Maxentio - 2026 founded, Unfunded company
- Mmeet AI - Mercerville based, 2012 founded, Unfunded company
- Matthew25 AI - Unfunded company
- Mavi - Brazil based, Unfunded company
